Professor Stewart Kellie

Clinical Professor
Paediatrics & Child Health, Children's Hospital, Westmead

Telephone +61 2 9845 2122
Fax +61 2 9845 2171

Map

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Kellie, S. (2004). Serum Markers In Tumour Diagnosis And Treatment. In PN Plowman, R Pieters, CR Pinkerton (Eds.), Paediatric Oncology - Clinical Practice and Controversies, (pp. 169-188). United Kingdom: Hodder Education.

Journals

  • Peters, S., Glass, D., Reid, A., de Klerk, N., Armstrong, B., Kellie, S., Ashton, L., Milne, E., Fritschi, L. (2013). Parental occupational exposure to engine exhausts and childhood brain tumors. International Journal of Cancer, 132(12), 2975-2979. [More Information]
  • Howman-Giles, R., McCowage, G., Kellie, S., Graf, N. (2012). Extrarenal malignant rhabdoid tumor in childhood application of 18F-FDG PET/CT. Journal of Pediatric Hematology / Oncology, 34(1), 17-21. [More Information]
  • Zhong, Z., Paul, A., Kellie, S., O'Neill, G. (2010). Mesenchymal Migration as a Therapeutic Target in Glioblastoma. Journal of Oncology, 2010 (430142), 430142-1-430142-17. [More Information]
  • da Silva, N., Cappellano, A., Diez, B., Cavalheiro, S., Gardner, S., Wisoff, J., Kellie, S., Parker, R., Garvin, J., Finlay, J. (2010). Primary Chemotherapy for Intracranial Germ Cell Tumors: Results of the Third International CNS Germ Cell Tumor Study. Pediatric Blood & Cancer, 54(3), 377-383. [More Information]
  • Kellie, S., Howard, S. (2008). Global child health priorities: What role for paediatric oncologists? European Journal of Cancer, 44(16), 2388-96. [More Information]
  • Merchant, T., Kun, L., Krasin, M., Wallace, D., Chintagumpala, M., Woo, S., Ashley, D., Sexton, M., Kellie, S., Ahern, V., et al (2008). Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma. International Journal of Radiation: Oncology - Biology - Physics, 70(3), 782-787. [More Information]
  • Howman-Giles, R., Holland, A., Mihm, D., Montfort, J., Arbuckle, S., Kellie, S. (2008). Somatic malignant transformation in a sacrococcygeal teratoma in a child and the use of F18FDG PET imaging. Pediatric Surgery International, 24(4), 475-478. [More Information]
  • Kim, A., Ji, L., Balmaceda, C., Diez, B., Kellie, S., Dunkel, I., Gardner, S., Sposto, R., Finlay, J. (2008). The Prognostic Value of Tumor Markers in Newly Diagnosed Patients With Primary Central Nervous System Germ Cell Tumors. Pediatric Blood & Cancer, 51(6), 768-773. [More Information]
  • Darwish, B., Arbuckle, S., Kellie, S., Besser, M., Chaseling, R. (2007). Desmoplastic infantile ganglioglioma/astrocytoma with cerebrospinal metastasis. Journal of Clinical Neuroscience, 14(5), 498-501. [More Information]
  • Thompson, M., Fuller, C., Hogg, T., Dalton, J., Finkelstein, D., Lau, C., Chintagumpala, M., Adesina, A., Ashley, D., Kellie, S., et al (2006). Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Journal of Clinical Oncology, 24(12), 1924-1931.
  • Gajjar, A., Chintagumpala, M., Kellie, S., Kun, L., Ashley, D., Merchant, T., Woo, S., Wheeler, G., Ahern, V., Krasin, M., et al (2006). Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncology, 7(10), 813-820.
  • Coakley, J., Kellie, S., Nath, C., Munas, A., Cooke-Yarborough, C. (2005). Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid of infants. Annals of Clinical Biochemistry: an international journal of biochemistry in medicine, 42(Pt 1), 24-29. [More Information]
  • Kellie, S., Chaku, J., Lockwood, L., O'Regan, P., Waters, K., Wong, C. (2005). Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy. European Journal of Cancer, 41(11), 1588-1596. [More Information]
  • Sastry, J., Kellie, S. (2005). Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatric Hematology and Oncology, 22(5), 441-445. [More Information]
  • Cornwall, P., Murdoch, B., Ward, E., Kellie, S. (2004). Acoustic Investigation Of Vocal Quality Following Treatment For Childhood Cerebellar Tumour. Folia Phoniatrica et Logopaedica: international journal of phoniatrics, speech therapy and communication pathology, 56(2), 93-107.
  • Gajjar, A., Hernan, R., Kocak, M., Fuller, C., Lee, Y., McKinnon, P., Wallace, D., Lau, C., Chintagumpala, M., Ashley, D., Kellie, S., et al (2004). Clinical, Histopathologic, And Molecular Markers Of Prognosis: Toward A New Disease Risk Stratification System For Medulloblastoma. Journal of Clinical Oncology, 22(6), 984-993.
  • Kellie, S., Koopmans, P., Earl, J., Nath, C., Roebuck, D., Uges, D., de Graaf, S. (2004). Increasing The Dosage Of Vincristine: A Clinical And Pharmacokinetic Study Of Continuous-Infusion Vincristine In Children With Central Nervous System Tumors. Cancer, 100(12), 2637-2643. [More Information]
  • Kellie, S., Boyce, H., Dunkel, I., Diez, B., Rosenblum, M., Brualdi, L., Finlay, J. (2004). Intensive Cisplatin And Cyclophosphamide-Based Chemotherapy Without Radiotherapy For Intracranial Germinomas: Failure Of A Primary Chemotherapy Approach. Pediatric Blood & Cancer, 43(2), 126-133. [More Information]
  • Kellie, S., Boyce, H., Dunkel, I., Diez, B., Rosenblum, M., Brualdi, L., Finlay, J. (2004). Primary Chemotherapy For Intracranial Nongerminomatous Germ Cell Tumors: Results Of The Second International Cns Germ Cell Study Group Protocol. Journal of Clinical Oncology, 22(1), 846-853.
  • Stewart, C., Iacono, L., Chintagumpala, M., Kellie, S., Ashley, D., Zamboni, W., Kirstein, M., Fouladi, M., Seele, L., Wallace, D., et al (2004). Results Of A Phase Ii Upfront Window Of Pharmacokinetically Guided Topotecan In High-Risk Medulloblastoma And Supratentorial Primitive Neuroectodermal Tumor. Journal of Clinical Oncology, 22(16), 3357-3365.
  • Fouladi, M., Chintagumpala, M., Laningham, F., Ashley, D., Kellie, S., Langston, J., McCluggage, C., Woo, S., Kocak, M., Krull, K., et al (2004). White Matter Lesions Detected By Magnetic Resonance Imaging After Radiotherapy And High-Dose Chemotherapy In Children With Medulloblastoma Or Primitive Neuroectodermal Tumor. Journal of Clinical Oncology, 22(22), 4551-4560.
  • Cornwell, P., Murdoch, B., Ward, E., Kellie, S. (2003). Perceptual evaluation of motor speech following treatment for childhood cerebellar tumour. Clinical Linguistics and Phonetics, 17(8), 597-615.

2013

  • Peters, S., Glass, D., Reid, A., de Klerk, N., Armstrong, B., Kellie, S., Ashton, L., Milne, E., Fritschi, L. (2013). Parental occupational exposure to engine exhausts and childhood brain tumors. International Journal of Cancer, 132(12), 2975-2979. [More Information]

2012

  • Howman-Giles, R., McCowage, G., Kellie, S., Graf, N. (2012). Extrarenal malignant rhabdoid tumor in childhood application of 18F-FDG PET/CT. Journal of Pediatric Hematology / Oncology, 34(1), 17-21. [More Information]

2010

  • Zhong, Z., Paul, A., Kellie, S., O'Neill, G. (2010). Mesenchymal Migration as a Therapeutic Target in Glioblastoma. Journal of Oncology, 2010 (430142), 430142-1-430142-17. [More Information]
  • da Silva, N., Cappellano, A., Diez, B., Cavalheiro, S., Gardner, S., Wisoff, J., Kellie, S., Parker, R., Garvin, J., Finlay, J. (2010). Primary Chemotherapy for Intracranial Germ Cell Tumors: Results of the Third International CNS Germ Cell Tumor Study. Pediatric Blood & Cancer, 54(3), 377-383. [More Information]

2008

  • Kellie, S., Howard, S. (2008). Global child health priorities: What role for paediatric oncologists? European Journal of Cancer, 44(16), 2388-96. [More Information]
  • Merchant, T., Kun, L., Krasin, M., Wallace, D., Chintagumpala, M., Woo, S., Ashley, D., Sexton, M., Kellie, S., Ahern, V., et al (2008). Multi-Institution Prospective Trial of Reduced-Dose Craniospinal Irradiation (23.4 Gy) Followed by Conformal Posterior Fossa (36 Gy) and Primary Site Irradiation (55.8 Gy) and Dose-Intensive Chemotherapy for Average-Risk Medulloblastoma. International Journal of Radiation: Oncology - Biology - Physics, 70(3), 782-787. [More Information]
  • Howman-Giles, R., Holland, A., Mihm, D., Montfort, J., Arbuckle, S., Kellie, S. (2008). Somatic malignant transformation in a sacrococcygeal teratoma in a child and the use of F18FDG PET imaging. Pediatric Surgery International, 24(4), 475-478. [More Information]
  • Kim, A., Ji, L., Balmaceda, C., Diez, B., Kellie, S., Dunkel, I., Gardner, S., Sposto, R., Finlay, J. (2008). The Prognostic Value of Tumor Markers in Newly Diagnosed Patients With Primary Central Nervous System Germ Cell Tumors. Pediatric Blood & Cancer, 51(6), 768-773. [More Information]

2007

  • Darwish, B., Arbuckle, S., Kellie, S., Besser, M., Chaseling, R. (2007). Desmoplastic infantile ganglioglioma/astrocytoma with cerebrospinal metastasis. Journal of Clinical Neuroscience, 14(5), 498-501. [More Information]

2006

  • Thompson, M., Fuller, C., Hogg, T., Dalton, J., Finkelstein, D., Lau, C., Chintagumpala, M., Adesina, A., Ashley, D., Kellie, S., et al (2006). Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. Journal of Clinical Oncology, 24(12), 1924-1931.
  • Gajjar, A., Chintagumpala, M., Kellie, S., Kun, L., Ashley, D., Merchant, T., Woo, S., Wheeler, G., Ahern, V., Krasin, M., et al (2006). Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncology, 7(10), 813-820.

2005

  • Coakley, J., Kellie, S., Nath, C., Munas, A., Cooke-Yarborough, C. (2005). Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid of infants. Annals of Clinical Biochemistry: an international journal of biochemistry in medicine, 42(Pt 1), 24-29. [More Information]
  • Kellie, S., Chaku, J., Lockwood, L., O'Regan, P., Waters, K., Wong, C. (2005). Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy. European Journal of Cancer, 41(11), 1588-1596. [More Information]
  • Sastry, J., Kellie, S. (2005). Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatric Hematology and Oncology, 22(5), 441-445. [More Information]

2004

  • Cornwall, P., Murdoch, B., Ward, E., Kellie, S. (2004). Acoustic Investigation Of Vocal Quality Following Treatment For Childhood Cerebellar Tumour. Folia Phoniatrica et Logopaedica: international journal of phoniatrics, speech therapy and communication pathology, 56(2), 93-107.
  • Gajjar, A., Hernan, R., Kocak, M., Fuller, C., Lee, Y., McKinnon, P., Wallace, D., Lau, C., Chintagumpala, M., Ashley, D., Kellie, S., et al (2004). Clinical, Histopathologic, And Molecular Markers Of Prognosis: Toward A New Disease Risk Stratification System For Medulloblastoma. Journal of Clinical Oncology, 22(6), 984-993.
  • Kellie, S., Koopmans, P., Earl, J., Nath, C., Roebuck, D., Uges, D., de Graaf, S. (2004). Increasing The Dosage Of Vincristine: A Clinical And Pharmacokinetic Study Of Continuous-Infusion Vincristine In Children With Central Nervous System Tumors. Cancer, 100(12), 2637-2643. [More Information]
  • Kellie, S., Boyce, H., Dunkel, I., Diez, B., Rosenblum, M., Brualdi, L., Finlay, J. (2004). Intensive Cisplatin And Cyclophosphamide-Based Chemotherapy Without Radiotherapy For Intracranial Germinomas: Failure Of A Primary Chemotherapy Approach. Pediatric Blood & Cancer, 43(2), 126-133. [More Information]
  • Kellie, S., Boyce, H., Dunkel, I., Diez, B., Rosenblum, M., Brualdi, L., Finlay, J. (2004). Primary Chemotherapy For Intracranial Nongerminomatous Germ Cell Tumors: Results Of The Second International Cns Germ Cell Study Group Protocol. Journal of Clinical Oncology, 22(1), 846-853.
  • Stewart, C., Iacono, L., Chintagumpala, M., Kellie, S., Ashley, D., Zamboni, W., Kirstein, M., Fouladi, M., Seele, L., Wallace, D., et al (2004). Results Of A Phase Ii Upfront Window Of Pharmacokinetically Guided Topotecan In High-Risk Medulloblastoma And Supratentorial Primitive Neuroectodermal Tumor. Journal of Clinical Oncology, 22(16), 3357-3365.
  • Kellie, S. (2004). Serum Markers In Tumour Diagnosis And Treatment. In PN Plowman, R Pieters, CR Pinkerton (Eds.), Paediatric Oncology - Clinical Practice and Controversies, (pp. 169-188). United Kingdom: Hodder Education.
  • Fouladi, M., Chintagumpala, M., Laningham, F., Ashley, D., Kellie, S., Langston, J., McCluggage, C., Woo, S., Kocak, M., Krull, K., et al (2004). White Matter Lesions Detected By Magnetic Resonance Imaging After Radiotherapy And High-Dose Chemotherapy In Children With Medulloblastoma Or Primitive Neuroectodermal Tumor. Journal of Clinical Oncology, 22(22), 4551-4560.

2003

  • Cornwell, P., Murdoch, B., Ward, E., Kellie, S. (2003). Perceptual evaluation of motor speech following treatment for childhood cerebellar tumour. Clinical Linguistics and Phonetics, 17(8), 597-615.

To update your profile click here. For support on your academic profile contact .